(Q35005057)

5 August 2017

1 reference

title

N-3 fatty acids and diabetes (English)

1 reference

5 August 2017

0 references

Sirtori CR

1

1 reference

5 August 2017

Galli C

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Biomedicine and Pharmacotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

56

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

397-406

1 reference

n-3 polyunsaturated fatty acids and the cardiovascular system

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Dietary fat intake and prevention of cardiovascular disease: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

n-3 fatty acids and serum lipoproteins: human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Endocrine control of fatty acid desaturation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Diabetes puts myocardial n-3 fatty acid status at risk in the absence of supplementation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Increments of dietary linoleate raise liver arachidonate, but markedly reduce heart n-6 and n-3 fatty acids in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Fish oil prevents insulin resistance induced by high-fat feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Is it time for a clinical trial of dietary fish oil supplementation in individuals with NIDDM?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

ω-3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Fraudulent (and non fraudulent) fatty acids for human health

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Eicosapentaenoic acid (C20:5) augments glucose-induced insulin secretion from beta-TC3 insulinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Effect of glyburide andω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Changes in lipoprotein composition in hypertriglyceridemic patients taking cholesterol-free fish oil supplements

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

The effects of omega 3 and omega 6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Cardiovascular neural regulation explored in the frequency domain

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Heart Rate Variability and Progression of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900255-X

7 January 2021

10.1016/S0753-3322(02)00255-X

Identifiers

DOI

1 reference

5 August 2017

1 reference